• Medical_Professionals
• Medical_students
• Nurses

Conference Series LLC invites all the participants from all over the world to attend 5th International Conference on Cancer Genomics during August 8-9, 2016 in Las Vegas, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. 

Track:1 Cancer Nanotheranostics

Theranostics – a combination of the words therapeutics and diagnostics – describes a treatment platform that combines a diagnostic test with targeted therapy based on the test results, i.e. a step towards personalized medicine. Making use of nanotechnology materials and applications, theranostic nanomedicine can be understood as an integrated nanotherapeutic system, which can diagnose, deliver targeted cancer therapy and monitor the response to therapy.

Related Conferences:

5th World Congress on Cancer Therapy, September 28-30, 2015 Atlanta, Georgia, USA, International Conference on Molecular and Cancer Biomarkers September 15-17, 2016 Berlin, Germany ; 10th Global Annual Oncologists Meeting July 11-13, 2016 Cologne, Germany; 13th International Conference on Nanotek and Expo December 05-07, 2016 Seattle, USA, International Conference on Nano medicine, Drug Delivery, and Tissue Engineering (NDDTE'16), April 1 - 2, 2016, Prague, Czech Republic; MEDICON 2016, March 31- April 2, 2016 Paphos, Cyprus; 4th International Conference on Advanced Nanomaterial and Nanotechnology, Dec 8-11, 2015, Guwahati, India; NIPS 2016, December 4 - 9, 2016, Barcelona, Spain; 18th International Conference on Nanoscience, Nanotechnology and Engineering, September 29 - 30, 2016, London, United Kingdom

Track: 2 Whole Genome Sequencing

Whole genome sequencing also known as full genome sequencing, complete genome sequencing, or entire genome sequencing is a laboratory process that determines the complete DNA sequence of an organism's genome at a single time.

Related Conferences:

International Conference on Clinical and Molecular Genetics, November 28-30, 2016 Chicago, USA; 2nd International Conference on Transcriptomics August 18-20, 2016 Portland, Oregon USA; International Conference on Next Generation Sequencing July 21-22, 2016 Berlin, Germany; The Fourteenth Asia Pacific Bioinformatics Conference, 11th-13 January 2016, San Francisco, USA; World Congress on Human Genetics October 31- November 02, 2016 Valencia, Spain; 18th International Conference on Genetics and Genomics, June 9 - 10, 2016, San Francisco, USA; NGS ’16 Genome Annotation, April 4 – 6, 2016, Barcelona, Spain; Maintenance of Genome Stability 2016, March 7-10, 2016, Panama, Central America; Epigenomics: new marks, new horizons, December 2015, 2 December 2015, UK; Human Genome Meeting, 28 February – 2 March 2016, Houston, USA

Track: 3 Stem cells- Cancer

One of the most exciting recent developments in the field of cancer biology is the recognition that lineage progression continues to occur in tumours. In particular, there is an increasing body of evidence that like normaltissues, tumor cells that have the potential for unlimited self-renewal give rise in large numbers to cells that lack this potential - the so-called cancer stem cell hypothesis. By focusing for so many years on the majority cell populations in tumors, and not on the rarer cancer stem cells (cancer initiating cells), scientists and clinicians may have missed out on opportunities to understand, diagnose and treat the processes in cancer that matter most.

Related Conferences:

International Conference on Pancreatic and Colorectal Cancer, March 29-30, 2016, Atlanta, USA; International Conference on Prostate Cancer and Treatment, May 5-7, 2016, Chicago, USA; Cancer Diagnostics Conference and Expo June 13-15, 2016, Rome, Italy; International Conference on Tissue Engineering and Regenerative Medicine, Sept 12-14, 2016, Berlin Germany; Gene Regulatory Networks and the Encoded Causality of Development, May 16-18, 2016, California, USA; Stem Cell Models of Neural Degeneration and Disease, February 1-3, 2016 Dresden, Germany; Stem Cells and Cancer, March 6-10, 2016, Colorado, USA; Transdifferentiation and Tissue Plasticity in Cardiovascular Rejuvenation; February 7-10, 2016, West Sussex, UK

Track: 4 Trends in Cancer Genomics

The Cancer Cell Map Initiative: Defining the Hallmark Networks of Cancer- Progress in DNA sequencing has revealed the startling complexity of cancer genomes, which typically carry thousands of somatic mutations. Large-scale cancer genomics has further established a baseline that is now poised to effect the translation ofcancer genomics into the clinical setting, effectively transforming patient care. The barriers and challenges totranslation are significant, not the least of which involves the transition of research-grade computational and interpretational analysis to clinical-grade analysis.

Related Conferences:

International Conference on Cervical Cancer, 22-23 September, 2016 (Vienna, Austria); 6th World Congress on Cancer Therapy, 01-03 December, 2016 (Baltimore, USA); 13th Global Summit on Cancer Therapy 17-19 October, 2016 (Dubai, UAE); International Conference on Pancreatic and Colorectal Cancer, 29-30 March, 2016 (Atlanta, USA); Global Summit on Melanoma And Carcinoma, 14-15 July, 2016 (Brisbane, Australia); Chromatin and Epigenetic in Cancer ( Atlanta, Georgia); Advances in Ovarian Cancer Research: Exploiting Vulnerabilities (Orlando, Florida); Advance in Breast Cancer Research ( Washington, DC); Advances in Pediatric Cancer Research (Florida);  New Horizons in Cancer Research Conference (Sanghai, China).

Track: 5 Cancer Biopsy

Cancer is a heterogeneous genetic disease, and excisional biopsies provide only a snapshot in time of some of the rapid, dynamic genetic changes occurring in tumors. In addition, excisional biopsies are invasive, can’t be used repeatedly, and are ineffective in understanding the dynamics of tumor progression and metastasis. However, liquid biopsy, or blood-sample tests, under development by Epic Sciences can generate actionable information for oncologists by analyzing circulating tumor cells (CTCs) and fragments of tumor-cell DNA that are continuously shed by tumors into the bloodstream.

Related Conferences:

8th Euro Global Summit on Cancer Therapy November 03-05, 2015 Valencia, Spain; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; Cancer Diagnostics Conference and Expo June 13-15, 2016 Rome, Italy;  International Conference on Molecular and Cancer Biomarkers September 15-17, 2016 Berlin, Germany; International Conference on Cervical Cancer September 22-23, 2016 Vienna, Austria;  IBCC — 1st International & 8th Annual Breast Cancer Congress Dates28 Oct - 30 Oct 2015 Location Tehran, Iran; UCC — UAE Cancer Congress 29 - 31 Oct 2015 Dubai, United Arab Emirates; 4th Cancer Epigenetics Conference Nov 16-17, 2015 San Francisco, CA, United States.

Track: 6 Cancer  Genome Therapy

Numerous recent studies have demonstrated the use of genomic data, particularly gene expression signatures, as clinical prognostic factors in cancer and other complex diseases. These studies highlight the opportunity for strategies to achieve truly personalized cancer treatment. Particularly important has been the use of genome-scale gene expression analyses to identify discrete disease classes not previously recognized.

Related Conferences:

International Conference on Next Generation Sequencing, July 21-22, 2016 Berlin, Germany; 4th International Conference on Integrative Biology, July 18-20, 2016, Berlin, Germany, International Conference on Clinical and Molecular Genetics, November 28-30, 2016 Chicago, USA; International Conference on Molecular & Cancer Biomarkers, September 15-17 2016, Berlin, Germany; 5th International Conference on Cell and Gene Therapy, May 19-21, 2016 San Antonio, USA; Cancer Genome (Q1), February 7-11, 2016, Alberta, Canada; 18th International Conference on Cancer Genomics, January 26 - 27, 2016, Jeddah, Saudi Arabia; Enhancer Malfunction in Cancer (Q6), February 21-24, 2016, New Mexico, USA; DNA Damage, Mutation and Cancer, March 13-18, 2016, Ventura, USA; Chromatin and Epigenetics, 20 March 2016, Dubrovnik, Croatia

Track: 7 Epigenetics and cancer genomics

The field of cancer epigenetics is evolving rapidly on several fronts. Advances in our understanding of chromatin structure, histone modification, transcriptional activity and DNA methylation have resulted in an increasingly integrated view of epigenetics. In response to these insights, epigenetic therapy is expanding to include combinations of histone deacetylase inhibitors and DNA methyltransferase inhibitors.

Related Conferences:

International Conference on Genetics Counseling and Genomics Medicine, Aug 11-12, 2016, Birmingham, UK; Biotechnology World Convention, Aug 15-17, 2016, Sao Paulo, Brazil; International Conference on Synthetic Biology, Aug 18-19, 2016, London, UK, Annual Conference on Bio Science, Sept 12-13, 2016, Berlin, Germany; Noncoding RNAs in Health and Disease, February 21-24, 2016, Santa Fe, USA; Maintenance of Genome Stability March 7- 10, 2016, Panama, South America; Chromatin and Epigenetics, March 20-24, 2016 Whistler, Canada; Chromatin, Non-Coding RNAs and RNAP II Regulation in Development and Disease, March 29, 2016, Austin, USA; Chromatin Structure and Function, May 22-27, 2016, Les Diablerets, Switzerland

Track: 8 Cancer Nanotechnology

Nanotechnology is increasingly finding use in the management of cancer. Nanoscale devices have impactedcancer biology at three levels: early detection using, for example, Nano cantilevers or nanoparticles; tumour imaging using radio contrast nanoparticles or quantum dots; and drug delivery using nanovectors and hybrid nanoparticles.

Related Conferences:

5th World Congress on Cancer Therapy, September 28-30, 2015 Atlanta, Georgia, USA, International Conference on Molecular and Cancer Biomarkers September 15-17, 2016 Berlin, Germany ; 10th Global Annual Oncologists Meeting July 11-13, 2016 Cologne, Germany; 13th International Conference on Nanotek and Expo December 05-07, 2016 Seattle, USA, International Conference on Nano medicine, Drug Delivery, and Tissue Engineering (NDDTE'16), April 1 - 2, 2016, Prague, Czech Republic; MEDICON 2016, March 31- April 2, 2016 Paphos, Cyprus; 4th International Conference on Advanced Nanomaterial and Nanotechnology, Dec 8-11, 2015, Guwahati, India; NIPS 2016, December 4 - 9, 2016, Barcelona, Spain; 18th International Conference on Nanoscience, Nanotechnology and Engineering, September 29 - 30, 2016, London, United Kingdom

USD

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

Welcome to the Official Attendee Housing Site for the Cancer Genomics 2016, which will be held in the festive city of Las Vegas. The conference will take place in the following location and dates: 

Embassy Suites by Hilton Las Vegas

Swenson Street

Las Vegas

Nevada 89119, USA

TEL: +1-702-795-2800

FAX: +1-702-795-1520

Submission Info

Drop us an email for Program enquiry.

cancergenomics@conferenceseries.net

Sponsors / Exhibiting / Advertising.

cancergenomics@insightconferences.com

General Queries.

cancergenomics@conferenceseries.com

Drop us an email for Program enquiry.

cancergenomics@conferenceseries.net

Sponsors / Exhibiting / Advertising.

cancergenomics@insightconferences.com

General Queries.

cancergenomics@conferenceseries.com